Ligand Pharmaceuticals (LGND) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free LGND Stock Alerts $72.52 -6.35 (-8.05%) (As of 04/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLigand Pharmaceuticals (NASDAQ:LGND) Stock Price Down 5.2%marketbeat.com - April 18 at 4:55 PMWall Street Analysts Predict a 45.56% Upside in Ligand (LGND): Here's What You Should Knowfinance.yahoo.com - April 17 at 3:24 PMLigand Pharmaceuticals' (LGND) Buy Rating Reaffirmed at Benchmarkamericanbankingnews.com - April 14 at 1:52 AMLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Sees Significant Drop in Short Interestmarketbeat.com - April 13 at 4:57 PMSmith Graham & Co. Investment Advisors LP Has $5.94 Million Stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)marketbeat.com - April 12 at 12:46 PMLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Purchased by Impax Asset Management Group plcmarketbeat.com - April 10 at 10:46 AMCan Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Performance Keep Up Given Its Mixed Bag Of Fundamentals?finance.yahoo.com - April 9 at 10:39 AM7 Small-Cap Stocks for the Thinking Speculatorinvestorplace.com - April 8 at 2:46 PMLigand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conferencebusinesswire.com - April 8 at 8:15 AMQ2 2025 Earnings Forecast for Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Issued By Zacks Researchmarketbeat.com - April 5 at 8:51 AMLigand Pharmaceuticals (NASDAQ:LGND) Shares Gap Up to $74.73marketbeat.com - April 4 at 1:20 PMLigand Pharmaceuticals Incorporated Expected to Post Q1 2025 Earnings of $0.98 Per Share (NASDAQ:LGND)marketbeat.com - April 4 at 9:29 AMChicago Capital LLC Lowers Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)marketbeat.com - April 2 at 6:37 AMLigand (LGND) Down 15.5% Since Last Earnings Report: Can It Rebound?finance.yahoo.com - March 28 at 3:46 PMLigand Pharmaceuticals gains amid bullish investor pitchmsn.com - March 27 at 9:00 PMPacer Advisors Inc. Raises Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)marketbeat.com - March 26 at 7:56 AMLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Purchased by Deutsche Bank AGmarketbeat.com - March 21 at 4:12 AMLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Sold by Ziegler Capital Management LLCmarketbeat.com - March 20 at 12:06 PMLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Director Stephen L. Sabba Sells 1,893 Sharesinsidertrades.com - March 17 at 7:59 AMLGND Apr 2024 70.000 putfinance.yahoo.com - March 16 at 5:04 PMLGND Apr 2024 110.000 callfinance.yahoo.com - March 16 at 5:04 PMQube Research & Technologies Ltd Buys 24,610 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)marketbeat.com - March 11 at 5:23 AMLigand Pharmaceuticals Incorporated (LGND)uk.finance.yahoo.com - March 6 at 7:49 PMLigand Pharmaceuticals to Present at Barclays 26th Annual Global Healthcare Conferencebusinesswire.com - March 5 at 4:05 PMLigand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)businesswire.com - March 4 at 8:00 AMLGND Aug 2024 110.000 callca.finance.yahoo.com - March 3 at 11:54 PMLGND Apr 2024 90.000 callca.finance.yahoo.com - March 3 at 11:54 PMAnalysts Offer Insights on Healthcare Companies: Fulcrum Therapeutics (FULC), Ligand Pharma (LGND) and Alphatec Holdings (ATEC)markets.businessinsider.com - February 28 at 1:03 PMLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 28 at 1:03 PMLigand Pharmaceuticals Full Year 2023 Earnings: Beats Expectationsfinance.yahoo.com - February 28 at 8:03 AMWhy Is Ligand Pharmaceuticals Stock Trading Higher Today?msn.com - February 27 at 3:45 PMLigand Pharmaceuticals (NASDAQ:LGND) Shares Gap Up to $74.42marketbeat.com - February 27 at 11:48 AMLigand Reports Fourth Quarter and Full Year 2023 Financial Resultsfinance.yahoo.com - February 27 at 10:44 AMLigand Pharmaceuticals Inc (LGND) Reports Solid Earnings Amidst Operational Transformationfinance.yahoo.com - February 27 at 10:44 AMLigand Pharmaceuticals (NASDAQ:LGND) Releases FY24 Earnings Guidancemarketbeat.com - February 27 at 9:27 AMLigand Reports Fourth Quarter and Full Year 2023 Financial Resultsbusinesswire.com - February 27 at 7:00 AMLigand Pharmaceuticals's Earnings: A Previewbenzinga.com - February 26 at 6:36 PMLigand Pharmaceuticals Q4 2023 Earnings Previewmsn.com - February 26 at 1:35 PMCommonwealth of Pennsylvania Public School Empls Retrmt SYS Decreases Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)marketbeat.com - February 24 at 4:51 AMLGND Mar 2024 65.000 putfinance.yahoo.com - February 23 at 1:48 AMEsai gets Japanese approval for epilepsy drug using Ligand technologymsn.com - February 22 at 8:39 PMLigand Partner Eisai Receives Approval in Japan for Injection Formulation of Antiepileptic Drug Fycompa®businesswire.com - February 22 at 4:01 PMDeutsche Bank AG Buys 40,958 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)marketbeat.com - February 22 at 5:25 AMWhy Ligand Pharmaceuticals (LGND) Dipped More Than Broader Market Todayfinance.yahoo.com - February 20 at 7:51 PMLigand Pharmaceuticals (LGND) Set to Announce Earnings on Tuesdaymarketbeat.com - February 20 at 5:49 AMLigand Pharmaceuticals Expands Senior Leadership Team with Two Key Hiresbusinesswire.com - February 16 at 8:00 AMLigand to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024finance.yahoo.com - February 13 at 6:50 PMLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Acquired by Victory Capital Management Inc.marketbeat.com - February 13 at 4:20 AMHere's Why Ligand Pharmaceuticals (LGND) Fell More Than Broader Marketfinance.yahoo.com - February 12 at 8:51 PMIllinois Municipal Retirement Fund Takes Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)marketbeat.com - February 4 at 5:04 AM Get Ligand Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LGND and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. LGND Media Mentions By Week LGND Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LGND News Sentiment▼0.980.50▲Average Medical News Sentiment LGND News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LGND Articles This Week▼64▲LGND Articles Average Week Get Ligand Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LGND and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DVAX News Today IRWD News Today MNKD News Today GERN News Today OPK News Today INVA News Today NRIX News Today ARCT News Today PRAX News Today CMPS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LGND) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressBiden’s $374B Giveaway Into This SectorDTIA.I. Pioneer Issues Urgent Warning to AmericansTradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop 5 AI Stocks to Buy for 2024Market Moving TrendsHow Biden has already won 2024Porter & CompanyTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ligand Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.